Report Overview:
IVF is also known as In-Vitro Fertilization. In this process, sperm and egg together are fused into Petri Dish. After successful fertilization, IVF treatment is complete.
In 2012, global IVF market had a value of $9.3 billion. It is further forecast to reach $21.6 billion by the end of 2020. Late marriages and pregnancy cases among women are enhancing the Global IVF Market since fertility reduces with age. Some other factors that work positively for Global IVF market are changing lifestyles, rise in stress levels, smoking etc. As per the global data, number of infertile couple worldwide was 48.5 million in 2010. Further, there is a higher success rate of pregnancy in the age group 35-39 with IVF treatment.
Complete Report is Available At:
http://www.researchbeam.com/in-vitro-fertilization-market
High cost that IVF treatment demands is one major factor impeding force for global IVF market due to a higher possibility of infertile couple not conceiving in in the first IVF cycle. Patient would require to undergo multiple IVF cycles to become pregnant, which increases the total cost of IVF treatment. Approximate cost for IVF procedure would be around $10,000-$20,000 and hence, in nation with low income groups, IVF treatment has a lesser scope. Less awareness about the IVF treatment in developing nations such as Nigeria also poses a stiff challenge for Global IVF market. In order to increase the awareness. Medical tourism and low cost IVF procedure must be encouraged.
Below are dominant market player in IVF market:
Vitrolife AB,
Cook Medicals,
Cooper Surgical. Inc
Thermo Scientific,
GeneaBiomedx,
Irvine Scientific Inc
Oxford Gene Technology
EMD SeronoInc
Ova Science
AuxogynInc
KEY BENEFITS
Detailed analysis of the global IVF market, segmentation based on reagents and media,technology,instruments, geographies and end users.
Quantitative breakdown of the present market trends and analysis during the forecast period of...